Lice treatment study for children and adults
Part of Infections, Skin clinical trials.
This study tests a new medical device for head lice compared to a standard anti-lice shampoo. It aims to see if the device is safe and works well for people with mild to moderate lice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 2 years old.
- You must have a mild to moderate head lice infestation (no more than 24 lice).
- Your hair must be straight to wavy (not very curly or frizzy) and not longer than shoulder length.
- You must not be pregnant or planning to become pregnant during the study.
- You must agree not to use other lice treatments or cut or chemically treat your hair during the study.
- You must not have used any anti-lice treatment in the past 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new head lice product (X92001483) to see how safe and effective it is compared to the standard treatment Nix. It looks at both getting rid of lice and preventing them from coming back.
This study tests a new shampoo to treat head lice. It is for people with mild to moderate lice and compares the new shampoo to a standard treatment.
This study compares a new lice lotion to a standard lice shampoo to see how well they work and if they are safe. If you or your child has head lice, participating could help find a better way to get rid of them.
This study tests a new antidandruff lotion designed to restore the natural balance of microbes on your scalp. If you have moderate to severe dandruff and are generally healthy, this trial may help improve your dandruff with a specially formulated product.
This study tests a new medication called nemolizumab for people with lichen planopilaris (LPP), a type of scarring hair loss. It aims to see if the drug can help reduce scalp itching and improve the condition.
This study tests a new experimental drug called PG-033 in healthy adults. It helps doctors find out if the drug is safe and how your body processes it at different dose levels.
Hear when a new Lice; Head Lice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.